Eleven Drugs Lose Medicare Part B Pass-Through Status In 2009 Proposal
Executive Summary
CMS will issue its annual proposed changes to the list of drugs and biologicals designated as "pass-through" products under Medicare Part B, with 11 losing that status for 2009, 10 remaining on the list, and no drugs added